Health
Proton Therapy Shows Promising Survival and Quality-of-Life Gains for Lung Cancer
Prospective data show proton beam therapy improves survival while sparing healthy tissue and preserving quality of life in lung cancer patients.
Key Takeaways
- Proton therapy achieves 64% three-year survival for stage III lung cancer versus 24-38% with conventional radiation
- Median survival reached 49.1 months compared to 28.7 months for matched patients receiving standard X-ray treatment
- Patients showed significantly fewer severe side effects including lower rates of radiation pneumonitis and esophagitis
DE
DT Editorial AI··via medicalxpress.com